Patents by Inventor Rachel Nechushtai

Rachel Nechushtai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240082169
    Abstract: The present invention provides nanoparticle carriers of active agents which are functionalized by stimuli-responsive conjugation with DNA-nano structures, methods and processes for their preparation, compositions comprising them and uses thereof in methods of treating diseases, disorders and symptoms thereof.
    Type: Application
    Filed: January 17, 2022
    Publication date: March 14, 2024
    Applicant: Yissum Research Development Company of The Hebrew University of Jerusalem Ltd.
    Inventors: Itamar WILLNER, Eli PIKARSKY, Rachel NECHUSHTAI, Yang-Sung SOHN, Pu ZHANG, Yu OUYANG
  • Patent number: 11208443
    Abstract: The present invention provides peptides comprising a sequence derived from the human NAF-1 protein, analogs of said sequence or a retro-inverso sequence of said peptide or analog. The conjugates of such peptides are provided as well. The peptides and the conjugates of the present invention are useful in treating cancer, and in particular cancer in which the expression of NAF-1 is enhanced.
    Type: Grant
    Filed: February 12, 2018
    Date of Patent: December 28, 2021
    Assignee: YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.
    Inventors: Rachel Nechushtai, Assaf Friedler, Anat Iosub-Amir, Merav Darash-Yahana, Yang-Sung Sohn, Dorit Michaeli
  • Publication number: 20190375805
    Abstract: The present invention provides peptides comprising a sequence derived from the human NAF-1 protein, analogs of said sequence or a retro-inverso sequence of said peptide or analog. The conjugates of such peptides are provided as well. The peptides and the conjugates of the present invention are useful in treating cancer, and in particular cancer in which the expression of NAF-1 is enhanced.
    Type: Application
    Filed: February 12, 2018
    Publication date: December 12, 2019
    Inventors: Rachel NECHUSHTAI, Assaf FRIEDLER, Anat IOSUB-AMIR, Merav DARASH-YA-HANA, Yang-Sung SOHN, Dorit MICHAELI
  • Patent number: 8350007
    Abstract: The present technology relates to the fields of crystallography, biochemistry, and drug design. In particular, methods and compositions for screening, identifying and designing compounds that interact with human mitoNEET.
    Type: Grant
    Filed: August 15, 2008
    Date of Patent: January 8, 2013
    Assignees: The Regents of the University of California, Yissum, Research Development Company of Hebrew University of Jerusalem
    Inventors: Patricia A Jennings, Jack Dixon, Rachel Nechushtai
  • Publication number: 20110269939
    Abstract: The present technology relates to the fields of crystallography, biochemistry, and drug design. In particular, methods and compositions for screening, identifying and designing compounds that interact with human mitoNEET.
    Type: Application
    Filed: August 15, 2008
    Publication date: November 3, 2011
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Patricia A. Jennings, Jack Dixon, Rachel Nechushtai
  • Patent number: 6315724
    Abstract: An ultrasonic imaging system including a probe containing at least one ultrasonic transducer and at least one inertial sensor as well as electronic circuitry connected to the probe for causing the at least one ultrasonic transducer to transmit ultrasonic energy into a region and to receive reflected ultrasonic energy therefrom, creating a plurality of generally two-dimensional images whose geometrical relationship is indicated by outputs from the at least one inertial sensor.
    Type: Grant
    Filed: October 19, 1999
    Date of Patent: November 13, 2001
    Assignee: Biomedicom LTD
    Inventors: Michael Berman, James Gessert, Wayne Moore, Rachel Nechushtai, Hillel Rom, Ziv Soferman